|
Synonyms: Arcalyst® | IL-1 Trap | interleukin-1 Trap
rilonacept is an approved drug (FDA (2008), EMA (2009))
Compound class:
Peptide or derivative
Comment: Rilonacept is a fusion protein consisting of the binding domains of the IL-1 receptor (IL-1R) and the IL-1 receptor accessory protein (IL-1RAcP) linked to the Fc portion of human IgG1.
|
Classification  |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (FDA (2008), EMA (2009)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 8750 | rilonacept |
| Synonyms |
| Arcalyst® | IL-1 Trap | interleukin-1 Trap |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 217 |
| Other databases | |
| CAS Registry No. | 501081-76-1 |
| ChEMBL Ligand | CHEMBL1201830 |
| DrugBank Ligand | DB06372 |
| GtoPdb PubChem SID | 178103396 |
| Search PubMed clinical trials | rilonacept |
| Search PubMed titles | rilonacept |
| Search PubMed titles/abstracts | rilonacept |
| Wikipedia | Rilonacept |
